A judge has refused to summarily dismiss a claim that the Federal Court has inherent power to order the winding up of a foreign company even if the company has no business in Australia and is not subject to the Corporations Act.
The Full Federal Court has dismissed appeals by both parties to a ruling that dismissed allegations of infringement of a patent for an industrial machine safety system that uses laser fields to detect hazards.
Fairfax Media has asked a court to lift a suppression order on the name of a proposed witness the Daily Telegraph had sought to call in Geoffrey Rush’s defamation trial, which the actor won earlier this month.
Flight Centre has been hit with legal action on behalf of employees accusing the travel giant of short-changing its workers through commission-based payments.
International law firm King & Wood Mallesons has nabbed two leading litigators to bolster the ranks of its dispute resolution practice, the firm said Friday.
Security guard union United Voice has lost a challenge to a ruling that found Wilson Security could legally allocate overtime to Sundays over a four-week roster to avoid paying penalty rates.
Energy drink giant Red Bull has won judgment against South Korea’s Bullsone in a battle over the auto parts company’s Australian trade mark for a leaping red and black bull.
Qantas has failed in its bid to appeal a decision by the Fair Work Commission to allow a terminated employee’s late unfair dismissal application to proceed because the worker’s solicitor was to blame for the delay.
Lawyerly will be closed on Thursday, April 25 in observance of Anzac Day. We will resume regular daily publishing on Friday, April 26 and newsletter distribution on Monday, April 29. If you have any trouble accessing your Lawyerly account or have subscription enquiries during this time, please email subscriptions@lawyerly.com.au.
A judge has refused an application by generic drug maker Juno Pharmacueticals to withdraw an admission in a battle with Millennium Pharmaceuticals over its cheap version of breakthrough cancer drug Velcade, denying Juno a potential defence to allegations of patent infringement.